- +129.7% price growth over the last year
- High gross margin of 92.0%
- Low bankruptcy risk (Altman Z-Score: 8.56)
Maze Therapeutics, Inc. Common Stock stock upgraded from Sell Candidate to Buy Candidate after Thursday trading session
(Updated on Jun 18, 2026)
The Maze Therapeutics, Inc. Common Stock stock price gained 3.38% on the last trading day (Thursday, 18th Jun 2026), rising from $24.84 to $25.68. During the last trading day the stock fluctuated 3.27% from a day low at $24.96 to a day high of $25.77. The price has been going up and down for this period, and there has been a 1.1% gain for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 581 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $26.86 million.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -25.16% during the next 3 months and, with a 90% probability hold a price between $15.84 and $27.78 at the end of this 3-month period.
MAZE Signals & Forecast
The Maze Therapeutics, Inc. Common Stock stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $24.35 and $25.39. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 8.91%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Maze Therapeutics, Inc. Common Stock stock
On the downside, the stock finds support just below today's level from accumulated volume at $24.27 and $23.93. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Maze Therapeutics, Inc. Common Stock finds support just below today's level at $24.27. If this is broken, then the next support from accumulated volume will be at $23.93 and $23.66.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.82 between high and low, or 3.27%. For the last week, the stock has had daily average volatility of 3.90%.
Our recommended stop-loss: $24.63 (-4.10%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 8 days ago.)
Trading Expectations (MAZE) For The Upcoming Trading Day Of Monday 22nd
For the upcoming trading day on Monday, 22nd we expect Maze Therapeutics, Inc. Common Stock to open at $25.47, and during the day (based on 14 day Average True Range), to move between $25.03 and $26.33, which gives a possible trading interval of +/-$1.30 (+/-5.20%) up or down from last closing price. If Maze Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 5.20% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $24.27 (5.49%) than the resistance at $27.68 (7.79%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Maze Therapeutics, Inc. Common Stock stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score:
2.954
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on June 22, 2026 - $25.47 ( 0.82%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
MAZE Performance
Trading levels for MAZE
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 26.28 | 2.35% |
| R2 | 25.97 | 1.14% |
| R1 | 25.78 | 0.388% |
| Price | 25.68 | |
| S1 | 25.16 | -2.04% |
| S2 | 24.96 | -2.79% |
| S3 | 24.65 | -4.00% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 31.73 | 23.56% |
| R2 | 28.09 | 9.38% |
| R1 | 27.68 | 7.79% |
| Price | 25.68 | |
| S1 | 24.27 | -5.49% |
| S2 | 23.93 | -6.81% |
| S3 | 23.66 | -7.87% |
FAQ
Click here for our free guide on how to buy Maze Therapeutics, Inc. Common Stock Stock.
Buy MAZE